Regulated Information

Full-year 2023 revenue (presentation)

Financial presentations

2.67 MB • January, 30th 2024

Full-year 2023 revenue (press release)

Financial releases

191.13 KB • January, 30th 2024

Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 12 2023

Voting rights

61.25 KB • January, 17th 2024

Elis announces the signing of an agreement for the acquisition of Moderna Holding BV in the Netherlands

Press releases

92.87 KB • January, 10th 2024

Termination and implementation of the liquidity contract

Share buy-back programs and liquidity contract

58.38 KB • January, 2nd 2024

Appointment of BW Gestão de Investimentos as member of Elis Supervisory Board

Press releases

59.85 KB • December, 18th 2023

Disclosure of the number of shares forming the capital and of the number of voting rights as of 30 11 2023

Voting rights

61.18 KB • December, 11th 2023

S&P Global Ratings upgrades Elis to an Investment Grade credit BBB- rating

Press releases

85.5 KB • November, 17th 2023

Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 10 2023